Connor, Clark & Lunn Investment Management Ltd.

Position in WVE — Wave Life Sciences, Inc.

CIK 1596800 VANCOUVER, A1

Position in WVE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,361,636

-$2,167,692 QoQ

Shares Held

406,478

-34.9% QoQ

Ownership

0.206%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#59

of 237 holders

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. WVE ranks #45 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,361,636	406,478	-34.9%	Shares	Sole	2026-08-13
2026-03-31	$4,529,328	624,735	+804.4%	Shares	Sole	2026-05-11
2025-12-31	$1,174,326	69,078	-45.2%	Shares	Sole	2026-02-10
2025-03-31	$1,018,451	126,046	-67.5%	Shares	Sole	2025-05-12
2024-12-31	$4,797,964	387,871	+19.3%	Shares	Sole	2025-02-10
2024-09-30	$2,665,073	325,009	-4.3%	Shares	Sole	2024-11-08
2024-06-30	$1,695,347	339,749	-26.6%	Shares	Sole	2024-08-09
2024-03-31	$2,854,130	462,582	—	Shares	Sole	2024-05-09
No filing history on record for this holder in this stock.